Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ipsen is a global biopharmaceutical group focused on innovation and specialty care. The company develops and commercializes innovative medicines in three key therapeutic areas: Oncology, Rare Diseases, and Neuroscience. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of leading biotechnological and life sciences hubs. With a presence in over 100 countries, Ipsen sells more than 20 drugs and has a direct commercial presence in over 30 countries, aiming to improve patients' lives through innovative therapeutic solutions.
Serves as the global corporate center, housing key leadership and overseeing strategic direction, global operations, R&D coordination, financial management, and administrative functions for the company worldwide.
Modern office facilities designed to promote collaboration and efficiency, located in a dynamic business environment with excellent connectivity to Paris and international transport links.
Fosters a culture of innovation, collaboration, and patient-centricity. The HQ environment supports cross-functional teamwork and global interaction, reflecting Ipsen's international scope and commitment to scientific excellence.
The strategic nerve center for Ipsen, facilitating global decision-making, research and development oversight, and coordination of its international commercial activities. Its location provides access to a rich ecosystem of talent, research institutions, and business partners.
Ipsen operates on a global scale, supporting a wide array of functions across numerous countries. These include research and development in Oncology, Rare Diseases, and Neuroscience; manufacturing and supply chain logistics; commercial operations such as sales, marketing, and market access; as well as medical affairs, regulatory affairs, and corporate support functions. This expansive network enables Ipsen to develop, produce, and deliver its medicines to patients in over 100 countries worldwide.
65 Quai Georges Gorse
Boulogne-Billancourt
Île-de-France
France
Address: 650 East Kendall Street, Cambridge, MA 02142
Serves as Ipsen's primary center for research and development in North America, fostering partnerships with leading academic institutions and biotech companies in the Boston area to advance its pipeline.
Address: 102 Bath Road, Slough, SL1 3XE
Acts as a strategic base for Ipsen's UK and Ireland operations, managing commercialization, medical affairs, and supporting clinical development programs.
Address: Building 1, Lane 500, Chenhui Road, Pudong New Area, Shanghai
Drives Ipsen's growth in the rapidly expanding Chinese healthcare market, tailoring strategies to local needs and collaborating with regional partners to improve patient access to innovative treatments.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ipsen' leadership includes:
Ipsen has been backed by several prominent investors over the years, including:
In the past year, Ipsen has experienced key leadership adjustments, including the appointment of a new Chief Financial Officer and an ad interim Head of Research & Development, following the departure of the previous R&D Head. These changes reflect strategic shifts and the company's focus on strengthening its executive team.
Discover the tools Ipsen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ipsen predominantly uses the 'firstname.lastname@ipsen.com' email format for its employees. While other formats might exist in specific cases, this is the most common and reliable structure for professional communication.
firstname.lastname@ipsen.com
Format
john.smith@ipsen.com
Example
98%
Success rate
Ipsen Press Release • May 23, 2024
Ipsen announced new efficacy and safety data for Bylvay® (odevixibat) in Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC), presented at the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Annual Meeting....more
Ipsen Press Release • May 16, 2024
Ipsen reported positive topline results from the Phase III RESILIENT study evaluating Onivyde® (irinotecan liposome injection) plus 5-fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after failure of gemcitabine-based first-line therapy. The study met its primary endpoint of overall survival....more
Ipsen Press Release • April 25, 2024
Ipsen announced its financial results for the first quarter of 2024, showcasing robust sales growth propelled by its key products in Oncology, Rare Diseases, and Neuroscience. The company also reaffirmed its financial guidance for the full year 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ipsen, are just a search away.